Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erwinaze IV PK in ALL/LBL with E. coli asparaginase allergy
NCT01643408Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Nov 2012
- Primary completion
- Aug 2013
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of Asparaginase erwinia chrysanthemi in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), sponsored by Jazz Pharmaceuticals plc. Started Nov 2012; status: completed.
02
Drugs
Asparaginase erwinia chrysanthemi
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT01643408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01643408.